维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

3篇 您的检索式：作者名="Dengkui Mo"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Non-wood Forest Information Extraction Based on ALOS Data 显示文摘	Enping Yan Hui Lin Dengkui Mo	2010	Seventh International Conference on Fuzzy System and Knowledge Discovery (FSKD)2010，，5：	1
	2	Development and Validation of 2-band EVI with MODIS Data in Southeast China 显示文摘	Dengkui Mo Enping Yan Hui Lin	2012	ICMIC 2012 on IEEE2012，，1：	1
	3	LncRNA-POIR knockdown promotes hepatocellular carcinoma sensitivity to sorafenib through upregulating miR-182-5p and inhibiting autophagy显示文摘Although sorafenib has been found to prolong the survival time of patients with hepatocellular carcinoma(HCC),sorafenib resistance remains an important challenge.Increasing studies have demonstrated that long noncoding RNAs(lncRNAs)contribute to drug resistance in a wide number of cancers.Human periodontal ligament stem cell(PDLSC)osteogenesis impairment-related lncRNA(POIR)is a recently defined lncRNA for which little is known regarding its function.Our study aimed to reveal the role of POIR in the development of HCC cell sorafenib resistance.The level of POIR expression in patients and tumor cells was examined by Reverse transcription-quantitative polymerase chain reaction(RT-qPCR)assay.CCK-8,EdU,and flow cytometry assay were adopted to examine cell viability,proliferation,and apoptosis,respectively.The autophagy-associated protein expressions were determined by western blotting and autophagic flux analysis.The results of this study exhibited increased POIR in HCC tissues and cells and may be correlated with sorafenib resistance.Knockdown of POIR elevated sorafenib sensitivity by suppressing autophagy in HCC cells.Mechanically,POIR knockdown upregulated miR-182-5p,implying that miR-182-5p mediates POIR regulation.MiR-182-5p overexpression significantly enhanced chemosensitivity to sorafenib,whereas miR-182-5p inhibition had the opposite effect.The sensitization of POIR siRNA to sorafenib was abolished by co-transfection with miR-182-5p inhibitor.Our findings provide a potential target for further clinical treatment of sorafenib-resistant HCC patients.	JIAN XU HAILONG GE CHEN CHAO FENG MO YU WANG DENGKUI ZHANG XIAOXIAO ZHENG LI ZHENG XUEMEI LU WEI CHEN QUN XU WEIXIN YU	2022	BIOCELL2022，46，6：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费